Ravgen Gets $272.5 Million Verdict against Labcorp

CEO SUMMARY: In September, a jury returned a $272.5 million verdict against Labcorp, representing royalties owed to biotech company Ravgen for infringement of its diagnostic genetic test patent. Soon after, Quest Diagnostics settled a similar lawsuit with Ravgen before its trial began. The victories against the two largest commercial labs illustrate the risks of navigating …

Ravgen Gets $272.5 Million Verdict against Labcorp Read More »

To access this post, you must purchase The Dark Report.

Ravgen Gets $272.5 Million Verdict against Labcorp

Quest Diagnostics quickly settles similar litigation with biotech company over patented genetic tests

Comments

TABLE OF CONTENTS

Need A Group Membership? Company Discounts are Available!

You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

You have read 0 of 1 of your complimentary articles this month